Chemomab Therapeutics (CMMB) Pension (2017 - 2019)

Chemomab Therapeutics (CMMB) posted Pension of $10000.0 for Q3 2019, little changed on a QoQ basis from $10000.0 in Q2 2019.

Chemomab Therapeutics (CMMB) Pension (2017 - 2019) Analysis & Trends

Chemomab Therapeutics' Pension history runs 3 years deep, the most recent figure standing at $10000.0 for Q3 2019.

Quarterly Pension changed N/A year-over-year to $10000.0 in Q3 2019, while the trailing twelve-month figure through Sep 2019 was $10000.0 (changed N/A YoY) and the FY2018 annual result came in at $210000.0, up 6900.0% from the prior year.
Pension was $10000.0 for Q3 2019 at Chemomab Therapeutics, roughly flat from $10000.0 in the prior quarter.
Across five years, Pension topped out at $210000.0 in Q4 2018 and bottomed at $3000.0 in Q4 2017.
A 3-year average of $58250.0 and a median of $10000.0 in 2019 frame the typical range for Pension.
Peak annual rise in Pension reached 6900.0% in 2018, while the deepest fall reached 6900.0% in 2018.
Chemomab Therapeutics' Pension stood at $3000.0 in 2017, then soared by 6900.0% to $210000.0 in 2018, then plunged by 95.24% to $10000.0 in 2019.
Business Quant data shows CMMB's Pension at $10000.0 in Q3 2019, $10000.0 in Q2 2019, and $210000.0 in Q4 2018.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn
4	NuCana	279.75 Bn	279.75 Bn	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-
10	Chemomab Therapeutics	124.14 Mn	113.77 Mn	-

Download Data